EKR Therapeutics

March 2008
Bedminster, PA / Growth Capital


EKR is a specialty pharmaceutical company providing novel products that offer broad therapeutic potential and superior outcomes to acute-care hospitals.EKR was acquired by Cornerstone Therapeutics in June 2012.

Status

Realized

View All Companies

Contact

Scott Perricelli
Scott Perricelli / Partner

Contact Scott